Praziquantel Tablets 23 mg Feline Cestocide

Manufacturer
FELIX PHARMACEUTICALS PRIVATE LIMITED
Effective date
2026-01-13
Label type
Prescription Animal Drug Label
Version
1
Source
full-release
Hydrated at
2026-06-01 02:45:51

Label at a glance#

ProductPraziquantel
Active ingredientPRAZIQUANTEL
Label structure19 sections

Dosage and administration

Praziquantel Tablets 23 mg Feline Cestocide may be administered directly per os or crumbled and mixed with the feed. The recommended dosage of praziquantel varies according to body weight. Smaller animals require a relatively larger dosage because of their higher metabolic rate. The optimum dose for each individual animal will be achieved by utilizing the following dosage schedule: Cats and Kittens*  4 pound and u...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Each Chewable Tablet contains 23 mg praziquantel.

DESCRIPTION

DESCRIPTION SECTION

Praziquantel Tablets 23 mg Feline Cestocide are sized for easy oral administration to either adult cats or kittens. The tablets may be crumbled and mixed with the feed.



INDICATIONS

SPL UNCLASSIFIED SECTION

Praziquantel Tablets 23 mg Feline Cestocide are indicated for the removal of the following canine cestodes: Dipylidium caninum and Taenia,taeniaeformis.



 

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

There are no known contraindications to the use of praziquantel in cats.

ACTION

SPL UNCLASSIFIED SECTION

Praziquantel Tablets are absorbed, metabolized in the liver and excreted in the bile. Upon entering the digestive tract from the bile, cestocidal activity is exhibited.1

Following exposure to praziquantel, the tapeworm loses its ability to resist digestion by the mammalian host. Because of this, whole tapeworms, including the scolex, are very rarely passed after administration of praziquantel. In many instances only disintegrated and partially digested pieces of tapeworms will be seen in the stool. The majority of tapeworms killed are digested and are not found in the feces.



USE DIRECTIONS

SPL UNCLASSIFIED SECTION

Praziquantel Tablets 23 mg Feline Cestocide may be administered directly per os or crumbled and mixed with the feed. The recommended dosage of praziquantel varies according to body weight. Smaller animals require a relatively larger dosage because of their higher metabolic rate. The optimum dose for each individual animal will be achieved by utilizing the following dosage schedule:


Cats and Kittens*
 4 pound and under ½ tablet
 5-11 pounds. 1 tablet
Over 11 pounds 1½ tablets

*Not intended for use in kittens less than 6 weeks of age.

FASTING

SPL UNCLASSIFIED SECTION

The recommended dosage of praziquantel is not affected by the presence or absence of food in the gastrointestinal tract, therefore, FASTING IS NEITHER NECESSARY NOR RECOMMENDED.

RETREATMENT

SPL UNCLASSIFIED SECTION

For those animals maintained on premises where reinfections are likely to occur, clients should be instructed in the steps necessary to prevent reinfection; otherwise, retreatment may be necessary. This is especially true in cases of Dipylidium caninum infections where reinfection is almost certain to occur if fleas are not removed from the animal and its environment.


ANIMAL SAFETY

SPL UNCLASSIFIED SECTION

The safety index has been derived from controlled safety evaluations, clinical trials and prior approved use in foreign countries.

Dosages of 5 times the labeled rate at 14 day intervals to cats as young as 5½ weeks did not produce clinical signs of toxicity. No significant clinical chemistry, hematological, or histopathological changes occurred. Symptoms of gross overdosage include vomition, salivation, diarrhea and depression.

PREGNANCY

SPL UNCLASSIFIED SECTION

Praziquantel tablets have been tested in breeding and pregnant dogs. No adverse effects were noted.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

One instance of diarrhea and one of salivation (1.5%) were reported during the field trials in which 135 cats were administered praziquantel tablets 23 feline cestocide.

CONTACT INFORMATION

SPL UNCLASSIFIED SECTION

Contact Felix Pharmaceuticals Private Limited at 1-833-571-1525. To report suspected adverse drug experiences, contact Felix Pharmaceuticals Private
Limited at 1-833-571-1525. For additional information about reporting adverse drug experiences for animal drugs, contact FDA at 1-888-FDA-VETS or www.fda.gov/reportanimalae
To obtain a Safety Data Sheet(s), contact Felix Pharmaceuticals Private Limited at 1-833-571-1525.

WARNING

WARNINGS SECTION

Keep out of the reach of children. Not for human use.

STORAGE

SPL UNCLASSIFIED SECTION

Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].

HOW SUPPLIED

HOW SUPPLIED SECTION

Bottle of 3, 50 and 150 scored tablets.

Each scored tablet contains 23 mg praziquantel.



NDC Number 

Tablet Size

Tablets/Bottle

 86101-020-21

23 mg 

3 Tablets 

 86101-020-50

23 mg

50 Tablets

 86101-020-13

23 mg

150 Tablets 

REFERENCES

REFERENCES SECTION

1Andrews, P. Pharmacokinetic Studies with Droncit® in Animals Using a Biological Assay. Veterinary Medical Review 2/76: 154-165.

Approved by FDA under ANADA # 200-834


Distributed by:
Felixvet Inc.,
1300 NW Briarcliff Parkway,
Suite 100, Kansas City, Missouri 64150


Made in India


Neutral Code No. MP/DRUGS/25/90/2020


Rev. November 2025 

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 86101-020-21

Praziquantel Tablets

23 mg

Feline Cestocide

CAUTION: Federal (U.S.A) law restricts this drug to use by or on the order of a licensed veterinarian.

WARNING: KEEP OUT OF REACH OF CHILDREN. NOT FOR HUMAN USE.

EACH TABLET CONTAINS: 23 mg praziquantel

3 Chewable Tablets

Approved by FDA under ANADA # 200-834

container label-3 countcontainer label-3 count

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 86101-020-50

Praziquantel Tablets

23 mg

Feline Cestocide

CAUTION: Federal (U.S.A) law restricts this drug to use by or on the order of a licensed veterinarian.

WARNING: KEEP OUT OF REACH OF CHILDREN. NOT FOR HUMAN USE.

EACH TABLET CONTAINS: 23 mg praziquantel

50 Chewable Tablets

Approved by FDA under ANADA # 200-834

container label-50 countcontainer label-50 count

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 86101-020-13

Praziquantel Tablets

23 mg

Feline Cestocide

CAUTION: Federal (U.S.A) law restricts this drug to use by or on the order of a licensed veterinarian.

WARNING: KEEP OUT OF REACH OF CHILDREN. NOT FOR HUMAN USE.

EACH TABLET CONTAINS: 23 mg praziquantel

150 Chewable Tablets

Approved by FDA under ANADA # 200-834

container label-150 countcontainer label-150 count

  


DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
2733837praziquantel 23 MG Chewable TabletPSN1
2733837praziquantel 23 MG Chewable TabletSCD1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
PRAZIQUANTEL Pharmacologic Class Indexing3Indexing - Pharmacologic Class20190712

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130386101020131GTIN-13: 0386101020131
EAN-13: 0386101020131
GTIN-12: 386101020131
UPC-A: 386101020131
GTIN storage (14 digits): 00386101020131
container-150-count.jpg
BarcodeEAN-130386101020216GTIN-13: 0386101020216
EAN-13: 0386101020216
GTIN-12: 386101020216
UPC-A: 386101020216
GTIN storage (14 digits): 00386101020216
container-label-3-count.jpg
BarcodeEAN-130386101020506GTIN-13: 0386101020506
EAN-13: 0386101020506
GTIN-12: 386101020506
UPC-A: 386101020506
GTIN storage (14 digits): 00386101020506
contaier-label-50-count.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
8cabd598-669e-43ab-9753-4aec00a484cbProduct name120180125

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
86101-020-13Praziquantel150 in 1 BOTTLETABLET, CHEWABLE1501
86101-020-21Praziquantel3 in 1 BOTTLETABLET, CHEWABLE31
86101-020-50Praziquantel50 in 1 BOTTLETABLET, CHEWABLE501

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 1 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
86101-02086101-020-21, 86101-020-50, 86101-020-13

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 1 matching rows.

Name, UNII, Kind table
NameUNIIKind
PRAZIQUANTEL6490C9U457ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PRAZIQUANTELPRAZIQUANTELPar Health USA, LLC16f2b9c4-a260-4a31-bd52-e5945913246c2026-08-12Warnings, Adverse reactionsName fallback
brand name: PRAZIQUANTEL
generic name: PRAZIQUANTEL
BiltricidePRAZIQUANTELBayer HealthCare Pharmaceuticals Inc.34ce1cdd-648e-4f1e-8512-bf3d4cc22eb92026-03-02Warnings, Adverse reactionsName fallback
generic name: PRAZIQUANTEL

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.